Maze Therapeutics, Inc. (MAZE)

Last Closing Price: 31.20 (2026-11-18)

Debt to Capital Ratio (Quarterly)

Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)

Maze Therapeutics, Inc. (MAZE) had Debt to Capital Ratio of 0.08 for the most recently reported fiscal quarter, ending 2026-09-30.

Figures for fiscal quarter ending 2026-09-30
Income Statement Financials
--
$-47.97M
--
--
$51.52M
$-51.52M
$3.55M
$-47.97M
$-47.97M
$-47.97M
$-47.97M
$-47.97M
$-47.97M
$-51.52M
$-50.97M
60.87M
60.87M
$-0.79
$-0.79
Balance Sheet Financials
$400.10M
$4.35M
$111.45M
$511.56M
$28.30M
$39.12M
$54.71M
$83.01M
$428.55M
$428.55M
$428.55M
56.45M
Cash Flow Statement Financials
$-87.01M
$-153.64M
$205.56M
$190.34M
$155.24M
$-35.09M
$24.84M
--
--
Fundamental Metrics & Ratios
14.14
--
--
Debt to Capital Ratio
0.08
0.09
--
--
--
--
--
--
$-87.50M
--
--
--
--
--
--
--
-11.19%
-11.19%
-9.38%
-10.26%
$7.59
$-1.44
$-1.43